Orphan medicines launch excellence: sustaining launch success
pharmaphorum
JUNE 13, 2019
Launching orphan medicines excellently will become even more important over the next five years as more patients with rare diseases have pharmacotherapies available. There are also a growing number of disease-focussed registries, increasing public and policy maker awareness, and significant R&D investment in orphan drugs, as well as in digital technologies to support trials and treatment.
52 
Let's personalize your content